Thalidomide-O-C8-NH2 is primarily utilized in research and development for its potential therapeutic applications, particularly in the field of oncology. Its structure allows it to act as a modulator of the immune system and inflammation, making it a candidate for studying treatments for certain cancers, autoimmune diseases, and inflammatory conditions. Researchers explore its ability to inhibit angiogenesis, which is crucial in cutting off the blood supply to tumors, thereby hindering their growth. Additionally, its modified structure may enhance its bioavailability or target-specific interactions, making it a subject of interest in drug design and optimization studies. This compound is also investigated for its potential role in targeted drug delivery systems, where it could be conjugated to other molecules to improve efficacy and reduce side effects.